HealthcareAI Research5 min reading time

Novo Nordisk and AWS bring agentic AI into drug discovery

AI News (TechForge)
Read full post
Novo Nordisk is partnering with AWS to integrate AI agents into drug discovery, establishing a co-innovation hub in London to accelerate research from target identification to clinical dosing. The collaboration leverages AWS cloud and AI tools, including generative AI, to enhance workflows and reduce documentation time significantly.

More in Healthcare

UK Is Urged to Overhaul Regulation of AI-Medical Devices

Covered by 2 sources
Healthcare6 min read

NYU-DRP AI Model Predicts Five-Year Breast Cancer Risk From 3D Mammograms

Unite.AI

Google DeepMind releases AlphaGenome Atlas, a 1PB dataset of predicted molecular effects for all ~9B possible single-letter DNA changes in the human genome (Google)

Covered by 4 sources